Tudor Financial Inc. increased its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 36.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,822 shares of the company’s stock after acquiring an additional 2,897 shares during the period. Procter & Gamble comprises 1.1% of Tudor Financial Inc.’s investment portfolio, making the stock its 26th biggest holding. Tudor Financial Inc.’s holdings in Procter & Gamble were worth $1,814,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of PG. Acorn Creek Capital LLC boosted its position in shares of Procter & Gamble by 2.8% in the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after acquiring an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. increased its position in shares of Procter & Gamble by 1.1% during the 3rd quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock valued at $963,000 after purchasing an additional 59 shares during the last quarter. Traveka Wealth LLC lifted its holdings in shares of Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after acquiring an additional 60 shares during the last quarter. Allen Mooney & Barnes Investment Advisors LLC lifted its stake in Procter & Gamble by 0.7% in the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company’s stock worth $1,507,000 after purchasing an additional 61 shares during the last quarter. Finally, Valued Wealth Advisors LLC boosted its holdings in Procter & Gamble by 11.2% during the 3rd quarter. Valued Wealth Advisors LLC now owns 605 shares of the company’s stock valued at $105,000 after acquiring an additional 61 shares during the period. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble stock opened at $161.77 on Wednesday. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52-week low of $146.28 and a 52-week high of $180.43. The firm’s fifty day moving average is $169.09 and its 200 day moving average is $169.44. The company has a market cap of $380.96 billion, a price-to-earnings ratio of 27.89, a PEG ratio of 3.63 and a beta of 0.45.
Procter & Gamble Dividend Announcement
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Evercore ISI raised their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Barclays reduced their price target on shares of Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Royal Bank of Canada restated a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. Piper Sandler began coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target on the stock. Finally, Stifel Nicolaus lowered their target price on Procter & Gamble from $167.00 to $161.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $179.65.
View Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling
In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This represents a 54.48 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 73,447 shares of company stock worth $12,978,820 over the last three months. 0.18% of the stock is owned by insiders.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- What is the Dogs of the Dow Strategy? Overview and Examples
- SAP’s Strong Momentum: A Bullish Setup for Investors
- The How and Why of Investing in Gold Stocks
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.